ArticleHealthcare (Basel, Switzerland)2022

Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study.

Marco Montomoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.